Merck & Co. venture arm leads $10.3 million funding round for Gaithersburg-based superbug fighter OpGen - Washington Business Journal

OpGen Inc. (NASDAQ: OPGN) raised $10.4 million in a recent funding round led by the Merck Global Health Innovation Fund, the venture capital arm of pharmaceutical giant Merck & Co.